Chart

Intellia Therapeutics, Inc.

NTLA

Jan 1 1970 00:00:00

6.85

▼-0.5900▼-7.93%

Open7.36

High7.36

Low6.84

Close7.44

Volume403.16k

EPS

-5.25

P/E

-1.30

Market Cap

709.09M

Outstanding Shares

103.52M

Soon

Sentiment

Soon

Options

Recent Filings

ID: 0001193125-24-244201

ID: 0000950170-24-112980

ID: 0000950170-24-093907

ID: 0000950170-24-093339

ID: 0000950170-24-086061

ID: 0000950170-24-086046

ID: 0001193125-24-181015

ID: 0000950170-24-081259

ID: 0000950170-24-081258

ID: 0001193125-24-168545

You might find these companies interesting

Achieve Life Sciences, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

In Vitro & In Vivo Diagnostic Substances (2835)

Myriad Genetics Inc

In Vitro & In Vivo Diagnostic Substances (2835)

Mymd Pharmaceuticals, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Navidea Biopharmaceuticals, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Virax Biolabs Group Ltd

In Vitro & In Vivo Diagnostic Substances (2835)

Tnf Pharmaceuticals, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Lantheus Holdings, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

In Vitro & In Vivo Diagnostic Substances (2835)

Burzynski Research Institute Inc

In Vitro & In Vivo Diagnostic Substances (2835)

Nymox Pharmaceutical Corp

In Vitro & In Vivo Diagnostic Substances (2835)

Aspira Women's Health Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Regeneron Pharmaceuticals, Inc.

Pharmaceutical Preparations (2834)

Eiger Biopharmaceuticals, Inc.

Biological Products, (No Diagnostic Substances) (2836)